Greek Hospital Debts Settlement

3 February 1997

In Greece, a meeting between the Health Ministry and drug industryrepresentatives has agreed that companies which supply public hospitals with medicines and parapharmaceuticals will receive all the money owed by the government within four years (Marketletters November 25 and December 23).

Until last June 30, the hospitals owed the companies 141 billion drachmas ($546.2 million), and this total increased by 15 billion drachmas at the end of November. At the meeting, held on January 23, it was agreed that 5% of the debt would be paid within a few days, with 45% paid with government bonds of a two-year duration and the remaining 55% paid with government bonds of a three-year and four-year duration.

The government spokesmen said they were committed to ensuring that the government bonds could be liquidated as soon as possible.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight